- Dizocilpine
-
- $35.00 / 5mg
-
2025-12-10
- CAS:77086-21-6
- Min. Order:
- Purity: 99.97%
- Supply Ability: 10g
- Dizocilpine
-
- $1.00 / 1KG
-
2020-02-06
- CAS:77086-21-6
- Min. Order: 1KG
- Purity: 99%HPLC
- Supply Ability: 100KG
|
| | Dizocilpine Basic information |
| Product Name: | Dizocilpine | | Synonyms: | (5S)-5-Methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5α,10α-imine;[5S,10R,(+)]-10,11-Dihydro-5-methyl-5H-dibenzo[a,d]cyclohepten-5,10-imine;[5S,10R,(+)]-10,11-Dihydro-5-methyl-5H-dibenzo[a,d]cyclohepten-5α,10α-imine;C13737;MK-801 (Dizocilpine);5H-Dibenzo[a,d]cyclohepten-5,10-imine, 10,11-dihydro-5-methyl-, (5S,10R)-;Dizocilpine;Dizocilpine free base(MK801) | | CAS: | 77086-21-6 | | MF: | C16H15N | | MW: | 221.3 | | EINECS: | | | Product Categories: | Inhibitors | | Mol File: | 77086-21-6.mol |  |
| | Dizocilpine Chemical Properties |
| | Dizocilpine Usage And Synthesis |
| Uses | Neuroprotective. | | Definition | ChEBI: Dizocilpine is an organic heterotetracyclic compound that is 1-methyl-8-azabicyclo[3.2.1]octane ortho-fused to two benzene rings at positions 2-3 and 6-7 (the 5S,10R-stereoisomer). It is a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor and affects cognitive function, learning, and memory. It has a role as a NMDA receptor antagonist, an anaesthetic, an anticonvulsant, a nicotinic antagonist and a neuroprotective agent. It is a secondary amino compound and a tetracyclic antidepressant. It is a conjugate base of a dizocilpine(1+). | | in vivo | Dizocilpine maleate can be used to create schizophrenia models. An intraperitoneal injection of 0.2 mg/kg in SD rats results in a half-life of 52.31 minutes, an AUC of 3185.48 nM·min, and a clearance rate of 34 mL/min/kg[2].
Induction of Schizophrenia
Background
The specific mechanism of schizophrenia induction is unclear. One hypothesis is that, Dizocilpine maleateleads to dysregulation of glutamatergic system through NMDA inhibition[2].
Specific Modeling Methods
Rat: Sprague-Dawley ? male ? adult with weight of 250-300 g
Administration: 0.4 mg/kg ? i.p. ? single dose.
Note
Dizocilpine maleate is dissolved in 0.9% sterile saline.
Modeling Indicators Behavior: Increased spontaneous activity with obvious anxiety-like behavior, increased motor activity in longer diatance (hyperactivity), reduced time staying in central area (avoidance of central area).
Prepulse Inhibition (PPI): Decreased PPI significantly.
maze test:Avoided open arm entries in elevated plus maze test and reduced number of novel arm entries in Y maze test.
Correlated Product(s): Phencyclidine Opposite Product(s): Clozapine (HY-14539); Haloperidol (HY-14538) | | IC 50 | NMDA Receptor |
| | Dizocilpine Preparation Products And Raw materials |
| Raw materials | 5H-Dibenzo[a,d]cyclohepten-5,10-imine, 5-(bromomethyl)-10,11-dihydro-, (5S,10R)--->5H-Dibenzo[a,d]cyclohepten-5,10-imine-12-carboxylic acid, 5-cyano-10,11-dihydro-, ethenyl ester, (5S,10R)--->5H-Dibenzo[a,d]cyclohepten-5,10-imine-5-methanol, 10,11-dihydro-, (5S,10R)- |
|